How Jeff Sessions & Tom Price Could Derail the Cannabis Industry
Lukas Barfield
January 24th, 2017
Policy, Top News
California was the first state to pass medical cannabis in 1996. Two short years later Alaska, Colorado and Washington passed their own form of medical cannabis in 1998. Since that time 28 states and DC have legalized some form of full plant medical cannabis with the large majority now allowing limited CBD use with in their borders. Colorado and Washington passed recreational cannabis in 2012 and just 4 years later, a blink of the eye in politics, the count of states who allow recreational cannabis is up to 9. After decades of inaction, cannabis is officially on a roll. The Kohl Memo, released in 2013 in response to the CO and WA legalization efforts, has given recreational cannabis states a little space when it comes to cannabis regulation. Despite these clarifications and there being support for rescheduling cannabis from a Schedule I substance to a Schedule II substance, it is still illegal under Federal law. During this time of cannabis law legalization and relaxation pent up demand and innovation has produced a thriving legal cannabis industry that stretches from California to Maine, but the election of Donald J. Trump and his subsequent cabinet appointments of Senator Jeff sessions(R AL) to Attorney General and Representative Tom Price (R GA) to the Department of Health and Human Services threatens to undermined the economic and social justice gains cannabis has seen in recent years.
Trump himself, like many other issues on his plate, is vague when it comes to recreational cannabis, but in several interviews he has espoused support for medical cannabis. He told Bill O’Reilly in an interview in February 2016 after Bill pressed him on cracking down on recreational cannabis in Colorado. “I would really want to think about that one, Bill. Because in some ways I think it’s good and in other ways it’s bad. I do want to see what the medical effects are. I have to see what the medical effects are and, by the way — medical marijuana, medical? I’m in favor of it a hundred percent.” Citing people he knows who use medical cannabis, Trump has told other news outlets similar statements leading up to the election. Unfortunately, his two appointees Sessions and Price haven’t been as friendly to cannabis in the past.
The Attorney General is the top criminal prosecutor in the country. Sessions, if appointed, as AG will have broad discretion to enforce cannabis laws. Although he has not said explicitly what he will do in regards to cannabis he has made two ominous statements in the past that raised eyebrows in cannabis circles concerning the plant. In the 1980’s he said he used to like the KKK until he found out they smoked “pot”. Let that sink in for a moment. A more recent statement came in April 2016 when he said “Good people don’t smoke marijuana”. He added he thought the Obama policy was untenable. The latest signal Jeff Session’s cannabis policy may be different from the current administration’s came on January 10, 2017 during his confirmation hearing. He repeated his concerns around the Obama policy, and said he couldn’t promise that he wouldn’t enforce Federal law.
The Department of Health and Human Services is home to the Food and Drug Administration and other agencies that regulate cannabis and set research priorities in the US. Tom Price, who Like Sessions will have wide discretion to medal in cannabis’s new found success, has drawn critics from cannabis activist and industry insiders alike. His poor stance on cannabis law has earned him a score of -10 from NORML. They site the Georgia representative’s “No” vote on amendments designed to roll back Federal interference in state medical cannabis laws and amendments that would allow VA doctors to recommend cannabis to Veterans. Surprisingly, He has been reluctant to vote “No” on regulating high CBD cannabis products, but has not clarified his position through any public statement.
The Marijuana Business Fact Book forecasts the US cannabis industry will contribute 44 billion dollars per year to the economy by 2020. It was estimated to be worth 6.7 billion in 2016. With jurisdictions relaxing cannabis laws, states relying on cannabis to fill budget shortfalls, large investors wanting to get in on the fastest growing sector in the economy and mom and pop businesses sinking their life savings into their cannabis businesses the stakes are high. Cannabis is at a uncertain crossroads. The decisions the Trump administration makes over the next 4 years, for good or bad, could shape cannabis policy for years to come.
To learn more about key risks to the cannabis industry, sign-up for our free newsletter using the form to the right.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Lukas Barfield
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
Tim has over 22 years of investment experience as a portfolio manager, asset allocator, and capital markets professional across multiple asset classes, geographies, and platforms. Tim has built and operated two hedge funds, a broker dealer, and raised over $1Bn in capital for his combined businesses. Tim remains a recognized voice within the investment community […]
KetamineOne Capital is focused on consolidating medical clinics and becoming a North American leader in mental health treatments.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
